EPO published patent application EP3681997A1 for regulatory macrophages intended for treating angiopathies. The applicant is Ferring Ventures SA with inventor Fred Fändrich. The application is classified under IPC codes covering pharmaceutical compositions (A61K), cell therapy using C12N 5/0786 (regulatory macrophages), and multiple designated contracting states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.\n\nThis is a routine patent publication notice with no compliance requirements or deadlines. Entities interested in licensing this technology, conducting research in related areas, or monitoring competitor intellectual property should review the application details and consult the original EPO register for the full patent specification. No action is required from compliance teams unless involved in therapeutic macrophage development or related patent landscape analysis.